http://www.optinose.com
OptiNose, Inc. Company Intro
Optinose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear, nose, and throat (ENT) and allergy specialists.
Industry
Healthcare
OptiNose, Inc. Headquaters
1020 Stony Hill Road
Yardley,19067
United States
OptiNose, Inc. Share price
22 Jan 2021 02:18 GMT
$4.0800
0.02 (0.49 %)
OptiNose, Inc. Market cap
$213.01 M
WMC RANKING
2021
OptiNose, Inc. # 61
Drug Manufacturers—Specialty & GenericLatest OptiNose, Inc. News
11 Jan 2021
Nasal Drug Delivery Technology Market (covid-19 analysis) SWOT analysis, key indicators, forecast to 2026 | Aptargroup, Inc., Aegis Therapeutics LLC, 3M United States
Ltd, Glaxosmithkline PLC, Johnson & Johnson, Merck & Co., Inc., Novartis AG, OptiNose, Inc, PendoPharm, Inc, Pfizer, Inc, Promius Pharma, LLC, Shin Nippon ...
11 Jan 2021
Nasal Drug Delivery Technology Market (covid-19 analysis) SWOT analysis, key indicators, forecast to 2026 | Aptargroup, Inc., Aegis Therapeutics LLC, 3M United States
Ltd, Glaxosmithkline PLC, Johnson & Johnson, Merck & Co., Inc., Novartis AG, OptiNose, Inc, PendoPharm, Inc, Pfizer, Inc, Promius Pharma, LLC, Shin Nippon ...
11 Jan 2021
Nasal Drug Delivery Technology Market (covid-19 analysis) SWOT analysis, key indicators, forecast to 2026 | Aptargroup, Inc., Aegis Therapeutics LLC, 3M United States
Ltd, Glaxosmithkline PLC, Johnson & Johnson, Merck & Co., Inc., Novartis AG, OptiNose, Inc, PendoPharm, Inc, Pfizer, Inc, Promius Pharma, LLC, Shin Nippon ...
WMC Market Score
WMC Market to Revenue Score
OptiNose, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| OptiNose, Inc. | USD | $43,851 | $126,186 | $-100,917 | $2,130M | 61 |
| Teva Pharmaceutical Industries Limited | USD | $16,673,000 | $4,600,000 | $-4,031,000 | $135,880B | 1 |
| Bausch Health Companies Inc. | USD | $8,038,000 | $4,605,000 | $-1,923,000 | $94,120B | 2 |
| Zoetis Inc. | USD | $6,542,000 | $2,300,000 | $1,663,000 | $781,630B | 3 |
| Perrigo Company plc | USD | $4,709,800 | $1,348,000 | $246,500 | $59,260B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total OptiNose, Inc. Social Followers vs Top 4 Industry Competitors
OptiNose, Inc. Post vs Top 4 Industry Competitors
OptiNose, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
OptiNose, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
OptiNose, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| OptiNose, Inc. | 0.26 | 0 | 0 | 0 | 0 | 0 | 0 |
| Teva Pharmaceutical Industries Limited | 100 | 64.64 | 38.14 | 55 | 0 | 0 | 57.16 |
| Bausch Health Companies Inc. | 48.21 | 16.73 | 0 | 92 | 0 | 0 | 39.29 |
| Zoetis Inc. | 39.24 | 100 | 78.35 | 98 | 0 | 0 | 100 |
| Perrigo Company plc | 28.25 | 10.08 | 100 | 100 | 0 | 0 | 75.96 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
